The effects of storage temperature on PBMC gene expression by Jun Yang et al.
RESEARCH ARTICLE Open Access
The effects of storage temperature on
PBMC gene expression
Jun Yang1, Norma Diaz1, Joseph Adelsberger1, Xueyuan Zhou1, Randy Stevens1, Adam Rupert1, Julia A. Metcalf2,
Mike Baseler1, Christine Barbon3, Tomozumi Imamichi1, Richard Lempicki1 and Louis M. Cosentino3*
Abstract
Background: Cryopreservation of peripheral blood mononuclear cells (PBMCs) is a common and essential practice
in conducting research. There are different reports in the literature as to whether cryopreserved PBMCs need to
only be stored ≤ −150 °C or can be stored for a specified time at −80 °C. Therefore, we performed gene expression
analysis on cryopreserved PBMCs stored at both temperatures for 14 months and PBMCs that underwent
temperature cycling 104 times between these 2 storage temperatures. Real-time RT-PCR was performed to confirm
the involvement of specific genes associated with identified cellular pathways. All cryopreserved/stored samples
were compared to freshly isolated PBMCs and between storage conditions.
Results: We identified a total of 1,367 genes whose expression after 14 months of storage was affected >3 fold in
PBMCs following isolation, cryopreservation and thawing as compared to freshly isolated PBMC aliquots that did
not undergo cryopreservation. Sixty-six of these genes were shared among two or more major stress-related cellular
pathways (stress responses, immune activation and cell death). Thirteen genes involved in these pathways were
tested by real-time RT-PCR and the results agreed with the corresponding microarray data. There was no significant
change on the gene expression if the PBMCs experienced brief but repetitive temperature cycling as compared to
those that were constantly kept≤ −150 °C. However, there were 18 genes identified to be different when PBMCs were
stored at −80 °C but did not change when stored < −150 °C. A correlation was also found between the expressions of
2′–5′- oligoadenylate synthetase (OAS2), a known interferon stimulated gene (IFSG), and poor PBMC recovery post-thaw.
PBMC recovery and viability were better when the cells were stored≤−150 °C as compared to −80 °C.
Conclusions: Not only is the viability and recovery of PBMCs affected during cryopreservation but also their gene
expression pattern, as compared to freshly isolated PBMCs. Different storage temperature of PBMCs can activate or
suppress different genes, but the cycling between −80 °C and −150 °C did not produce significant alterations in gene
expression when compared to PBMCs stored≤−150 °C. Further analysis by gene expression of various PBMC processing
and cryopreservation procedures is currently underway, as is identifying possible molecular mechanisms.
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Background
Human peripheral blood mononuclear cells (PBMCs)
are a critical biological specimen type collected in clin-
ical trials and basic science research. PBMCs are used
for the evaluation of various in vitro functional and
phenotypic immunological assays, e.g., enzyme-linked
immunosorbent spot (ELISPOT) assays [1, 2], prolifera-
tion assays [3], flow cytometry [4] and cytometry by
time-of-flight (CyTOF) [5] determinations. They also
serve as precursors for potential immunotherapy devel-
opment [6] and are used for biomarker discovery [7, 8]
in translational medicine. Many times, PBMC samples
need to be collected, processed and cryopreserved at
multiple clinical sites. As a result, considerable attention
has been given to standardization and/or harmonization
[9–11] of the needed assay reagents and assay proce-
dures involved in the testing of these samples that meas-
ure the patient’s immune response or status. Testing
samples in batches is frequently an additional require-
ment in order to minimize assay variability; therefore,
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PBMC samples are often cryopreserved and stored at
ultra-low temperatures until they are tested. However,
the same level of standardization and consistency given
to the pre-analytical factors involved in the storage, ship-
ping and general sample handling of frozen cryopre-
served PBMCs has not been applied.
According to best practice [12], in order to maintain
viability of PBMCs, they need to be stored below −132 °C,
the glass transition temperature of water (GTTW). This
is the temperature, at or below, that all biological activ-
ity stops [13]. Often, biospecimen storage temperature
is chosen based on what type of equipment is available
at the location where the biospecimen processing and
cryopreservation will be performed. Some facilities,
both in the US and internationally, cannot easily get
liquid nitrogen for specimen storage below −132 °C. It
may also be difficult to provide liquid nitrogen to all fa-
cilities because of cost or design restrictions in their
physical plant. However, samples from these sites may
be deemed necessary for the project, e.g., achieving
planned participant enrollment numbers or satisfying a
demographic requirement. The use of mechanical −140 °C
freezers can be an option, but operating procedures
need to be in place to avoid repeatedly warming spec-
imens above the GTTW, especially when accessing
the freezer for sample retrieval.
These logistical challenges may make it impossible to
have PBMCs stored below −132 °C throughout its entire
life at all facilities. Weinberg, et al., reported that storage
of cryopreserved PBMCs for ≤ 3 weeks at −70 °C did not
affect cell viability, recovery or flow cytometry results
[14, 15]. Cryopreserved PBMCs have been reported to
be stored up to 1.5 years, in a mechanical −70 °C/-80 °C
freezer, depending on container type used, without
effecting viable cell recovery [16]. How long specimens
are at −70 °C/-80 °C may also be dictated by when the
samples will be relocated to the central biobank for long-
term storage before they are tested. This type of dual-
storage temperature approach may be under-reported in
the literature, especially since mechanical −70 °C/-80 °C
freezers are common equipment at most clinical trial
sites. Regardless, temperature fluctuations can occur
when specimens are being retrieved from storage, dur-
ing storage or when shipped. All of these situations
need to be avoided due to their negative affect on the
viability and functionality of PBMCs after they have
been thawed [2, 17].
Functional differences between freshly isolated PBMCs
and cryopreserved/thawed PBMCs have been well sum-
marized and reviewed [18]. These differences have been
attributed to reagents or procedures used to isolate and
cryopreserve the PBMCs [19–21] as well as how the
PBMCs were thawed [22]. Several cytokines have been
reported to be spontaneously released from thawed
cryopreserved PBMCs from Type 1 diabetic children but
not freshly isolated PBMCs [23]. Interferon-γ secretion
from PBMCs was one of the highest produced cytokines
identified from frozen thawed PBMCs [23, 24]. Likewise,
apoptosis and necrosis is detected after cryopreserved
PBMCs are thawed [25, 26]. This outcome has been de-
scribed as cryopreservation-induced delayed-onset cell
death (CIDOCD) [27], which accounts for the decrease
in PBMC viability and recovery [28].
In this report, we use gene expression analysis to iden-
tify several major stress-related cellular pathways and
real-time RT-PCR to confirm that specific genes associ-
ated with these pathways are affected when cryopre-
served PBMC samples are stored for 14 months at
different temperatures and then thawed. We also extend
our previous observations about how cell viability and
recovery are affected by cryopreservation by showing
how 2′–5′-oligoadenylate synthetase 2 (OAS2) gene ex-
pression in freshly isolated PBMCs inversely correlates
with their post-thaw viability. Specifically, gene expres-
sion analysis was conducted on fresh and cryopreserved
PBMCs under three different storage conditions. Sister
aliquots of PBMCs were all control-rate frozen down
to −150 °C and then stored: (1) at ≤ −150 °C, which is
considered the “gold standard” for storage temperature (2)
at ≤ −150 °C for 24 h and then 104 cycles of
computer-controlled thermal cycling with repetitive
warming to −80 °C and cooling back down to −150 °C;
and (3) at −80 °C. Gene expression of cryopreserved
PBMCs that were stored at these three storage conditions
for 14 months was compared to data from their freshly
isolated (non-frozen) PBMC sister samples. In all three
storage situations, the gene expression pattern was differ-
ent from their freshly isolated parent PBMCs. Flow cy-
tometry and viability were also determined from aliquots
of the fresh samples and all three storage conditions in
an attempt to obtain a comprehensive understanding of
two pre-analytical factors, storage temperature and
storage temperature fluctuations, during routine sample
handling. This work provides critical insight into the
molecular changes that are occurring within stored
PBMCs following hypothermic transition and storage in
a frozen state. This work also provides a foundation for
establishing scientifically-based “Best Practices” in spe-
cimen storage and for identifying biomarkers of quality
for cryopreserved PBMC specimens.
Conclusions
In the present study, we show that total/unfractionated
PBMCs that were cryopreserved and stored at <-150 C,
<-150 C + Cycled and -80 C for 14 months have differ-
ent gene expression patterns than their freshly isolated
counterpart. These changes tend to be related to two or
more major stress-related pathways (stress responses,
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immune activation and cell death). Of the 1,367 affected
genes that showed >3 foldchange, 66 of these genes were
shared among these stress-related pathways, which was
confirmed by real-time RT PCR for 13 representative
genes. PBMCs stored at -80 C for the same period of
time had a significantly lower viability post-thaw and
had 18 different genes altered than aliquots stored at
<-150 C or at <-150 C + Cycled. Specimen handling and
storage decisions may influence intended downstream
analysis when susing PBMCs. Therefore, being able to
measure gene expression of specific genes such as the
interferon stimultory gene, OAS2, allowed us to identify
a potentially useful biomarker of poor PBMC quality
post-thaw regardless of the storage temperature. Overall,
our results provide insight into the reason why it is im-
portant to store PBMCs below the GTTW, thus assisting
in the establishment of "Best Practices."
Methods
Blood donation
Blood was collected from 10 healthy donors in 2005
at the Frederick National Laboratory for Cancer
Research’s Normal Donor Program. Each donor signed
a NIH 2514–1, Consent to Participate in A Clinical
Research Study, under Study Number OH99-C-N046.
Whole blood was collected in Acid Citrate Dextrose
(ACD)-Solution Vacutainers (Becton Dickenson,
Franklin Lakes, NJ).
PBMC isolation
Whole blood was pooled from vacutainers, to create a
homogenate mixture prior to PBMC isolation. The
pooled whole blood was divided into 25 ml aliquots.
Plasma was collected from the whole blood by centrifu-
gation at 450 x g for 20 min at room temperature (RT),
and discarded. The cellular fraction of the whole blood
was diluted with RPMI 1640 media without L-
Glutamine (Quality Biologicals Inc., Gaithersburg, MD)
to bring the volume to 35 ml and gently resuspended
prior to PBMC isolation. PBMCs were isolated by dens-
ity centrifugation using Ficoll-Paque™ Plus (GE Health-
care Bio-Sciences Corp., Piscataway, NJ). Thirty-five mls
of the diluted cellular whole blood fraction was overlaid
onto 15 mls of the Ficoll-Paque Plus and then subjected
to 900 x g for 30 min at RT with the centrifuge brake
“off.” PBMCs were washed 2X with RPMI 1640 media
by centrifugation at 450 x g for 10 min at RT. PBMCs
were counted using Trypan Blue (Sigma, St. Louis, MO)
exclusion on a hemocytometer and light microscope.
Aliquots were segregated for gene expression analysis.
Control-rate freezing
The remaining PBMCs were placed in RPMI 1640 media
without L-Glutamine (RPMI 1640 media) supplemented
with 20 % heat-inactivated HyClone™ Fetal Bovine Serum
(FBS, Hyclone Laboratories Inc., Logan, UT) and 7.5 %
Dimethyl Sulphoxide Hybri-max® (Sigma, St. Louis, MO).
1 mL aliquots of 10 × 106 cells/ml were created and frozen
to −150 °C using a CryoMed Freezer (Thermo Electron
Corp., Marietta, OH) with the control-rate program
(start temperature +4 °C; −1C/min to −4 °C; −25 °C/
min to −40 °C; +15 °C/min to −12 °C; −1 °C/min to −40 °C;
−10 °C/min to −150 °C; hold at −150 °C for 10 min).
PBMC storage
PBMCs frozen to −150 °C were then stored under three
different conditions. Sister aliquots from each donor
were (1) placed in static ≤ −150 °C storage in the vapor
phase of a liquid nitrogen freezer, i.e., Stored ≤ −150 °C;
(2) cycled between −80 °C and −150 °C to mimic long-term
exposure to repository storage & sorting conditions, i.e.,
Stored ≤ −150 °C +Cycled (start at temperature of −150 °C;
increase +10 °C/min to −80 °C; hold at −80 °C for 10 min;
decrease −30 °C/min to −150 °C; hold at −150 °C for 10
min; the samples were cycled through this program
for 8 h per day for 13 days; final hold at −150 °C was
followed by transfer to vapor phase LN2 for the
duration of the storage period); and (3) placed in
static −80 °C storage, i.e., Stored −80 °C.
PBMC thawing
After 14 months of storage, samples were then rapidly
thawed at 37 °C. The cells were rinsed with RPMI 1640
media to remove residual DMSO, resuspended in RPMI
1640 media supplemented with 10 % heat-inactivated
FBS, and counted by Trypan Blue exclusion for total
count and viability. Gene expression analysis was given
preference over flow cytometry analysis when cell recov-
ery was low. PBMCs designated for gene expression ana-
lysis were placed in the RLT lysis buffer solution as
described in the Microarray Gene Expression Analysis
section below, and frozen at −80 °C until batch proc-
essed. PBMCs designated for flow cytometry were placed
in the RPMI 1640 media with 10 % FBS.
Flow cytometry of PBMCs
Flow cytometric analysis of ACD-anticoagulated ficoll-
hypaque isolated PBMCs was performed on a Becton
Dickinson LSRFortessa SORP flow cytometer (BD Bio-
sciences, San Jose, CA) and data analysis was performed
with DeNovo FCSexpress v4 flow cytometry analysis
software (DeNovo, Los Angeles, CA).
The PBMCs were washed in Annexin binding buffer
(BD Pharmingen, San Jose, CA) then stained with CD45
Brilliant Violet 510 (Clone HI30, Biolegend, San Diego,
CA). Annexin V (AnnV) PerCP-Cy5.5 (BD Pharmingen,
San Jose, CA) and 7-AAD (Invitrogen, Grand Island,
NY) to identify apoptosis/necrosis. The cells were gated
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on FS/SSC and CD45/SSC to identify leukocytes apop-
totic cells were identified as AnnV positive/7-AAD nega-
tive and necrotic cells were identified as AnnV positive/
7-AAD positive.
Microarray gene expression analysis
PBMCs were prepared for gene expression analysis by
removing the media from the cells, rinsing with room
temperature phosphate buffered solution pH 7.4 (Quality
Biologicals Inc., Gaithersburg, MD) and lysing the cells
via resuspension in Buffer RLT (Qiagen, Valencia, CA).
The lysed cell mixture was stored at −80 °C. Total RNA
was isolated from PBMCs that underwent different stor-
age conditions using Qiagen RNeasy kit by following
manufacturer’s protocol. Total RNA was quantitated and
qualified in Nanodrop 8000 and Agilent Bioanalyzer
RNA Nano 6000 chip before performing Affymetrix
GeneChip assays. Affymetrix Human GeneChip U133
Plus 2.0 Array (Affymetrix, Sacramento, CA) was used
and labeling assay was performed by following manufac-
turer’s protocol.
Microarray data was normalized and analyzed using
Partek Pro (St. Louis, MO). Genes were selected by 3-
way ANOVA statistical analysis and correlated with cell
viability flow cytometry data. The selection criteria are
P-value less than 0.05 and absolute fold change more
than 3. The correlation selection criteria are p-value is
less than 0.05 and inter-quartile value is more than 1.4.
Selected genes were normalized by medium shift before
hierarchy clustering. Biological function annotation
was done on in-house software DAVID [29] (http://
david.abcc.ncifcrf.gov/) and Ingenuity IPA software
(Qiagen, Germantown, MD).
Quantitative real-time reverse transcription PCR
(RT-PCR) assay
cDNA was synthesized from isolated total RNA (600 ng
from the same sample for microarray assay; a sample of
nuclease-free water was included as RT control) with Taq-
Man Reverse transcription Kit following manufacturer-
provided protocol (Applied Biosystems, Grand Island,
NY). Briefly, RNA was mix with 1 μL oligo d(T)16 (50 mM
in the kit) and then brought to a total volume of 9.6 μL
with nuclease-free water. The mixture was homogenized
and pelleted by brief vortex and centrifugation. Next, the
mixture was incubated at 65 °C for 5 min and then rested
at 4 °C for 2 min. After the initial treatment, 10.4 μL pre-
pared master mix was added to each sample. The master
mix was composed of the following reagents that were all
included in the kit: 2 μL 10 × RT buffer, 1.4 μL 25 mM
MgCl2, 4 μL 10 mM dNTP mix (2.5 mM each), 1 μL 100
mM DTT, 1 μL RNase inhibitor (20 U/ μL) and 1 μL Mul-
tiScribe RT (50 U/μL). The samples were then homoge-
nized and pelleted by brief vortex and centrifugation.
Next, the reaction was carried out at 37 °C for 30 min and
then deactivated at 95 °C for 5 min. After the deactivation,
the samples were set at 4 °C. Before quantitative PCR, the
volume of synthesized cDNA was brought up to 120 μL
with nuclease-free water. Each sample was run in tripli-
cate wells with 2 μL synthesized cDNA in each well (a
sample of nuclease-free water was also included as QPCR
blank control). 23 μL prepared QPCR master mix [12.5
μL 2 × TaqMan Universal PCR Master Mix (Applied Bio-
systems, Grand Island, NY), 1.25 μL 20× human GAPDH
primer and probe (Applied Biosystems, Grand Island, NY;
VIC-TAMRA-labeled probe), 1.25 μL 20× target gene pri-
mer and probe (Applied Biosystems, Grand Island, NY;
FAM-labeled probe) and 8 μL nuclease-free water for each
sample] was added to each well, homogenized and pel-
leted by brief vortex and centrifugation. The reaction was
carried on Applied Biosystems QuantStudio 12K Flex plat-
form (Applied Biosystems, Grand Island, NY) following
the conditions: 50 °C × 2 min (1×), 95 °C × 10 min (1×),
followed by 40 cycles of 95 °C × 15 s and 60 °C × 1 min.
After the QPCR reaction, the cycle number was obtained
by manually setting the threshold of GAPDH and tar-
get gene at 0.1 for all samples. The cycle numbers for
the same sample were close enough in triplicate wells
to guarantee the least variation of operation. Before
summarizing the results, the expression of target gene
was normalized to the expression of GAPDH in the
same well.
Results
Cryopreservation greatly impacts the PBMC transcriptome
A microarray cryopreservation study was performed
with a total of 39 PBMC samples from 10 healthy do-
nors that were evaluated after fresh isolation and follow-
ing storage for 14 months. All aliquots of PBMCs were
rate-controlled frozen and then handled and stored in
one of the following 3 ways before being evaluated for gene
expression: (1.) Stored ≤ −150 °C, (2.) Stored ≤ −150 °C +
Cycled and (3.) Stored −80 °C, (see “PBMC storage” in
Materials and Methods section for complete details).
Table 1 summarizes the number of significantly modu-
lated genes for each storage temperature and cycling, if
performed. Table 1 indicates that storage of PBMCs
under any of three conditions results in changes in a
large number of transcripts compared to freshly iso-
lated PBMCs. This is in contrast with the much lower
number of transcripts when comparing Stored ≤ −150 °C
to Stored ≤ −150 °C ± Cycled (no difference in transcript
levels) or Stored −80 °C (18–225 genes, depending on the
fold-change threshold). From herein, a fold-change cut-off
of >3 fold (1,367 unique genes in total; Additional
file 1.xlsx) was used in order to better manage the
biological interpretation of gene list as related to the
magnitude of the response. Of interest is the effect
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that cryopreservation has on the magnitude of de-
creasing the expression of certain genes as well in-
creasing gene expression.
Transcriptome profiles of cryopreserved PBMC are
associated with immune activation, stress response, and
cell death pathways
K-means clustering and heat map visualization were
used to summarize gene expression changes of the 1,367
selected genes relative to the median expression value of
a given gene within the “Fresh” samples (Fig. 1). The
data distributed into 2 major clusters, with Cluster 1
representing 753 genes with higher transcript levels on
average by cryopreservation compared to “Fresh” sam-
ples, and Cluster 2 representing 614 genes with lower
transcript levels compared to “Fresh”.
DAVID and Ingenuity Pathway (IPA) tools were used
to annotate and characterize the biological pathways
most associated with genes from Cluster 1 and 2. A se-
lect list of biological pathways enriched with transcripts
Table 1 Number of genes significantly modulated by different storage conditions
Comparison mRNA level change Number of genes (FC > 2) Number of genes (FC > 3)
Stored < −150 °C vs. Fresh Increased 1453 450
Decreased 1624 427
Stored≤ −150 °C + Cycled vs. Fresh Increased 1507 674
Decreased 1721 420
Stored −80 °C vs. Fresh Increased 1134 517
Decreased 2168 480
Stored≤ −150 °C + Cycled vs. Stored≤ −150 °C Increased 0 0
Decreased 0 0
Stored −80 °C vs Stored ≤ −150 °C Increased 56 8
Decreased 169 10
This table illustrates the number of genes with significantly (p < 0.05) higher or lower transcript levels following cryopreservation and thawing as compared to
freshly isolated PBMCs or between storage conditions using an absolute Fold-Change cut-off of >2 (FC2) or >3 (FC3)
Fig. 1 Visual summary of 1,367 differentially expressed genes following cryopreservation. The expressed genes from PBMC samples stored for 14
months in the 3 storage conditions are presented in Cluster 1 (increased expression) and Cluster 2 (decreased expression) as related to freshly
isolated PBMCs that have an absolute FC > 3
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was significantly altered following cryopreservation and
are shown in Table 2. Additional file 2.xlsx contains sup-
plemental information to Table 2 and contains the list of
genes associated with each of the biological pathways.
Toll-like Receptor Signaling, Regulation of Transcrip-
tion, NFkB Signaling, MAP Kinase Signaling Pathways
are associated with the set of elevated transcripts (Clus-
ter 1) whereas Cell Death and Defense Response Path-
ways were similarly associated with both Clusters 1 and
2. Figure 2 shows two pathways: the Kegg Map Kinase
Pathway and the IPA NFkB Signaling Pathway targeted
by the selected genes.
There were 66 genes out of 212 unique genes shared
between 2 or more biological pathways, which are
shown in Additional file 3. This observation suggests a
strong inter-connection between these pathways as a re-
sult of the cryopreservation procedure. Support for this
includes the modulation of early response genes from
MAP Kinase pathway such as MAP3K7, MAP3K8,
MAP4K4, MAPK6, DUSP2, DUSP4, DUSP5, DUSP7,
DUSP8, DUSP10, and PPM1L known to be modulated
by a variety of stress related stimuli including oxidative
stress, osmotic stress, membrane disruption, and heat or
cold shock. Modulation of the MAPK stress response
pathway has been shown to modulate a number down-
stream stress response pathways such as JUN Kinase,
cell death and DNA binding/transcription. Many such
MAPK kinase downstream regulated genes were modu-
lated in this study including NFKBIZ, NFKBIA, NFKB2,
NFKB1, JUND, JUN, GADD45A, GADD45B, FOSL2,
FOSL1, FOSB, FOS, ELK4, CASP1, BRAF, BCL3, BAG4,
and ARAF. Modulation of many of these genes are
linked to regulation of immune response genes such as
those seen in this study CCL2, CCL20, CCL7, CCR2,
CX3CR1,CXCL16, CXCL2, CXCL3, CXCR2, DEFA1,
IFNG, IL1A, IL1B, IL8, JAK2, STAT1, TLR4, TLR5,
TLR7, TLR8, TNF. Taken together, these results suggest
that the cryopreservation procedure of placing cells in a
high serum concentration cryococktail with DMSO,
cooling, freezing, storing and thawing modulate mRNAs
in pathways involved in cellular stress responses that im-
pact downstream response genes involved in cell death
and inflammation.
Thirteen genes that were common to the biological
pathways listed in Table 2 and Additional file 3 were an-
alyzed by real-time RT-PCR to confirm the microarray
analysis. The RT-PCR was performed on the RNA from
the 10 PBMC samples Stored ≤ −150 °C for 14 months and
on the 9 RNA samples from the PBMCs Stored −80 °C for
14 months. The Stored < −150 °C +Cycled PBMC RNA
samples were not tested since we had shown that cyc-
ling did not change the gene expression pattern from
that of Stored ≤ −150 °C PBMC RNA samples. This
data is presented in Table 3. All 13 genes have a
good agreement between the real-time RT-PCR data
and the microarray data at both temperatures. These
13 genes are involved in the 4 major biological path-
ways that were listed in Table 2, i.e., Interferon Signa-
ture, Cell Death-Related, Immune Regulatory, and
MAPK. The expression of 5 of the genes was shown
to be decreased and the expression other 8 genes was
increased.
Impact of cell storage conditions on cell viability
Trypan Blue was used to determine cell viability of
freshly isolated PBMCs from the 10 healthy donors plus
aliquots of the PBMCs that were cryopreserved, stored
for 14 months at each of the three storage conditions
and thawed. The viabilities as determined by Trypan
Blue were all ≥92 %. As a comparison, cell viability,
apoptosis, and necrosis were also evaluated by flow cy-
tometry following cell surface detection of Annexin A5
Table 2 Select biological categories significantly associated with differentially regulated genes
Pathway Tool Database Pathway Enrichment P-value Cluster Number of genes (% of Genes)
IPA Canonical Pathways Toll-like Receptor Signaling 4.70E-09 1 12 (16.7 %)
2 7 (9.7 %)
DAVID GO-BP Cell Death 5.80E-08 1 46 (10.6 %)
2 34 (9.4 %)
DAVID GO-BP Regulation of Transcription 9.90E-08 1 141 (32.3 %)
2 70 (19.4 %)
IPA Canonical Pathways NFkB Signaling 1.20E-06 1 17 (10.1 %)
2 9 (5.3 %)
DAVID GO-BP Defense Response 1.50E-05 1 36 (8.2 %)
2 27 (7.5 %)
DAVID KEGG MAPK Signaling Pathway 7.4E-04 1 27 (14.2 %)
2 7 (5.0 %)
This table summarizes the number genes associated with the common pathways identified by IPA and DAVID that were either in cluster 1 or 2
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Fig. 2 (See legend on next page.)
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(AnnV) and DNA staining with 7-aminoactinomycin D
(7-AAD). AnnV binds phosphatidylserine (PS) exposed
on the surface of cells undergoing apoptosis or exposed
by loss of plasma membrane integrity in necrotic cells.
The DNA of necrotic, but not apoptotic or viable cells,
is stained by the vital dye 7-AAD which and is excluded
by cells with an intact plasma membrane [30].
The percent of live cells as determined by AnnV and
7-AAD staining compared to Trypan Blue varied signifi-
cantly, both for fresh cells and more so for stored cells
(Fig. 3). Cell viability of freshly isolated PBMCs assessed
with AnnV and 7-AAD staining averaged 78.5 % +/−
2 %, as oppose to Trypan Blue of 96.3 % +/− 1.1. Cell
viability based on 7-AAD/AnnV decreased significantly
for all three storage conditions over 14 months as com-
pared to fresh PBMCs, most notably for Stored −80 °C;
Stored ≤ −150 °C 56.3 % +/− 2.8 % (P < 0.001),
Stored ≤ −150 °C + Cycled 51.6 % +/− 2.5 % (p <
0.001), and Stored −80 °C 39.4 % +/− 2.8 % (p <
0.001). There was no significant difference in cell
viability between Stored ≤ −150 °C and Stored ≤ −150 °C +
Cycled; however, Stored −80 °C PBMCs had significantly
lower viability than PBMCs at Stored ≤ −150 °C (p = 0.008).
These results are consistent with the microarray data
showing no significant gene expression differences between
Stored ≤ −150 °C and Stored ≤ −150 °C +Cycling using a 2-
fold change threshold whereas 225 genes were significantly
different between Stored ≤ −150 °C and Stored −80 °C.
However, using a 3-fold change threshold, there were
only 18 genes that were different between the PBMCs
Stored ≤ −150 °C and those Stored −80 °C. In addition to
declining viability during storage, the percentage of cells
recovered also declined over time (data not shown). Tak-
ing in consideration both cell viability and cell recovery,
we find that less than half of the PBMCs put into storage
can be recovered as viable cells after 1 year, even under
optimal storage conditions of Stored ≤ −150 °C. Interest-
ingly, no such significant decline in cell viability following
14 months of cryopreservation was observed by the use of
Trypan Blue indicating the inferiority of this method and
how misleading it is.
Interferon Stimulated Gene (IFSG) levels in fresh PBMC
samples predict cryopreservation quality
Potential biomarkers in fresh PBMC samples that are
predictive of cryopreservation quality were identified
by selecting genes from fresh samples that signifi-
cantly correlated with cell viability levels of PBMCs
(See figure on previous page.)
Fig. 2 Select Biological Pathways Significantly Associated with Differentially Regulated Genes. MAP Kinase Pathway (a) and NFKB Pathway (b) are
illustrated separately. The selected 1376 transcripts were overlaid in the KEGG MAPK signal pathway through DAVID analysis. The genes in the
selected list were marked with red starts. The same list of genes was overlaid on NF-kB signaling pathway through Ingenuity Pathway Analysis
software. The red color genes were genes in Cluster 1 (up-regulated by Cryopreservation) and the green color genes were the ones in Cluster 2
(Down-regulated by Cryopreservation)





Microarray data (Log2[FC]) RT-PCR data (ΔΔCT)
Stored≤ −150 °C to Fresh Stored −80 °C to Fresh Stored≤ −150 °C to Fresh Stored −80 °C to Fresh
Interferon Signature Genes MX1 −0.97 −0.88 −1.93 −1.17
MX2 −0.74 −0.50 −1.60 −0.91
IFNG 2.21 3.22 2.50 4.38
IFI16 −1.81 −1.47 −2.93 −1.77
OAS2 −1.79 −1.91 −3.29 −2.49
Cell Death-Related Genes GADD45B 2.10 2.49 1.48 2.61
FOSL2 3.14 2.98 2.19 2.49
Immune Response Genes IL1B 4.39 5.19 5.91 7.26
TNF 1.39 2.00 1.56 2.94
TNFSF10 −3.23 −2.72 −3.92 −2.88
MAPK Genes NFKB1 1.63 1.32 1.13 1.21
MAP3KB 3.07 3.20 1.93 2.05
DUSP4 4.59 4.10 5.85 6.07
aAbbreviations: MX1 (myxovirus [influenza virus] resistance 1, interferon-inducible protein p78 [mouse], MX2 (myxovirus [influenza virus] resistance 2 [mouse],
IFNG (interferon, gamma), IFI16 (interferon, gamma-inducible protein 16), OAS2 (2′–5′-oligoadenylate synthetase 2, 69/71 kDa), GADD45B (Growth arrest and DNA-
damage-inducible, beta), FOSL2 (FOS-like antigen 2), IL1B (interleukin 1, beta), TNF(tumor necrosis factor), TNFSF10 (tumor necrosis factor (ligand) superfamily,
member 10), NFKB1 (nuclear factor of kappa light polypeptide gene enhancer in B-cells 1), MAP3K8 (mitogen-activated protein kinase kinase kinase 8), and
DUSP4 (dual specificity phosphatase 4)
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when samples were kept at the three storage condi-
tions. While a number of potential biomarker genes
were identified (Additional file 2), a group of inter-
feron stimulated genes were consistently expressed at
higher levels in PBMC samples likely to demonstrate
poor cell viability in all three storage conditions
(Additional file 3). Figure 4 shows an example of one
such gene, the 2′5′-oligoadenylate synthetase 2 gene
(OAS2).
Each panel in Fig. 4, compares the expression of
OAS2 to thawed PBMCs after being cryopreserved
and kept at the 3 storage conditions: Plot A (Stored ≤
−150 °C), Plot B (Stored ≤ −150 °C + Cycled) and Plot
C (Stored −80 °C). At each storage temperature, the
expression of OAS2 was inversely related to the per-
cent cell viability of the PBMCs using 7-AAD/AnnV,
which is a further reason not to use or rely on the
results with Trypan Blue. The R value for each stor-
age condition is presented in Fig. 4. P values were
also calculated for each storage condition, 0.02, 0.002
and 0.037 respectively, thus demonstrating statistical
significance.
Discussion
Isolating and cryopreserving PBMCs from whole blood
is a multistep process. Each step in the process can be
variable due to the type and formulation of the reagent
used and the temperature and duration of the process
performed. Laboratories may have their preference for
specific processes and procedures used [18, 19]. There-
fore, we have begun a systemic investigation of how vari-
ous reagents and processes during PBMC isolation and
Fig. 3 Cell viability differences based on trypan blue and 7-ADD/AnnV. Viability of fresh, ≤ − 150 °C Stored, ≤ − 150 °C + Cycled and −80 °C Stored
were determined by trypan blue exclusion and by 7-ADD/AnnV
Fig. 4 OAS2 gene expression levels in fresh PBMC samples inversely correlates with 14 month cell viability of cells Stored≤ −150 °C (Plot a),
Stored≤ −150 °C + Cycled (Plot b) and Stored −80 °C (Plot c). P values were calculated for each plot: 0.02, 0.002, and 0.037, respectively
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cryopreservation could affect the gene expression of
PBMCs in an attempt to establish “Best Practice” recom-
mendations. It is our expectation that this detailed ap-
proach will reveal the use of certain reagents or the
performance of specific processes that could be critical
to identifying biomarkers of specific diseases instead of
identifying artificial biomarkers of poor sample handling
or storage. Specimen handling and storage decisions
could influence intended downstream analysis.
Therefore, in this paper, we evaluated the impact of
storing 10 healthy donor cryopreserved PBMCs at the
two most common biospecimen storage temperatures
(≤ − 150 °C and −80 °C) for 14 months. Even though cell
cryopreservation has become prevalent in research and
clinical applications since initial experiments demon-
strating the feasibility of the technology, and especially
since the advent of the use of DMSO cryoprotectants
[31, 32], the literature contains reports that differ greatly
between these two common storage temperatures or
their combination [12–16]. Long-term storage at ≤ −150 °C
is considered the “gold standard,” because this is below the
glass transition temperature of water (GTTW) [13] and all
biological activity is believed to be stopped. If viable and
functional cells are required post-thaw, this is the
temperature at which published “Best Practices” state
cells should be stored [12]. Whereas, storage of PBMCs
at −80 °C tends to be for a shorter period of time usu-
ally because of resource limitations; however, the litera-
ture has reported that it is acceptable for long-term
storage as long as the PBMCs are stored in polyvi-
nylchloride or polyolefin bags [16]. However, cryovials
of various sizes are the typical storage container for
cryopreserved PBMCs and are made of polypropylene.
Therefore, it is critical to understand the impact of ex-
tended storage time (14 months) on gene expression of
cryopreserved PBMCs as related to their viability.
While most conventional cryopreservation methods
offer protection of cell membrane integrity during the
transition through the hypothermic state to dormancy at
the GTTW, cells must contend with multiple other fac-
tors that can cause injury and affect viable recovery and
function, including temperature fluctuations during stor-
age, shipment and handling [15, 16, 19, 23, 24]. To ad-
dress the impact that temperature fluctuations may have
on cryopreserved PBMCs, we evaluated the effect of
controlled temperature fluctuations between −150 °C
and −80 °C, e.g., repetitive warming and cooling through
the GTTW, which can occur to bystander samples when
other sister PBMC-containing vials, are retrieved for
testing. We evaluated PBMC viability by two methods:
Trypan Blue and AnnV/7-AAD. As previously reported
by us [28] and others [33], Trypan Blue evaluation of
PBMC viability is not as sensitive as is using flow cytom-
etry using AnnV/7-AAD staining when evaluating
apoptosis, delayed apoptosis, or necrotic injury from
PBMCs post thawed [19, 20, 24, 25]. These events are
underreported when Trypan Blue alone is used to enu-
merate viable cells [20], and the data in this study reca-
pitulated the phenomenon of inaccuracy of Trypan Blue
assessments compared to dual usage of AnnV and 7-
AAD.
There was no difference in cell viability using AnnV/7-
AAD between PBMCs that were consistently stored
at ≤ −150 °C and those stored ≤ −150 °C + Cycled.
Likewise, Germann et al. performed a similar experiment
and found no change in viability by Trypan Blue but a
small decrease in T-cell function (−6.54 % ± 15.89) when
cryopreserved PBMCs were cycled under similar
temperature parameters and lengths of time at the ex-
treme temperatures [17]. Our current cycling data sup-
ports our previous results [34] that it is not the number of
brief exposures to a warmer temperature through the
GTTW that causes apoptosis/necrosis but rather the
length of time of a single exposure. In this paper, the hold
time at −80 °C was only 10 min with 104 cycles (17.3 total
hours at −80 °C) even though the entire temperature cyc-
ling took 52 h to complete. This total length of time was
similar to our earlier work [34], which was 48 h but the
samples were at −80 °C the entire time, which we believed
allowed an increase in apoptosis/necrosis to occur. Taken
together, it suggests that it is not the number of cycles or
the repetitive temperature changes to −80 °C, nor the ac-
cumulative length of time at the warmer temperature, but
rather being at the warmer temperature for a protracted
period of time. Forty-eight hours was selected because it
has relevance to the amount of time that could occur if a
specimen shipment is delayed in transit. However, it has
been reported that when the temperature inside a cryovial
of PBMCs increased to −60 °C, the viability of the PBMCs
did decrease even when it was exposed to the warmer
temperature for only 5 min [17]. In future work, we plan
to determine what the minimum amount of time is, and
other parameters needed to cause changes in the highly
expressed genes, that are associated with the identified
stress-related cellular pathways in cryopreserved PBMCs
as described in this paper. This data will help to inform la-
boratory and biorepository operational decision-making
on storage and specimen management.
The analysis of the gene expression patterns showed
that all cryopreserved PBMCs, regardless of storage
temperature or subjection to temperature fluctuations,
were significantly different than its freshly isolated non-
cryopreserved parent sample. This difference depended
on the fold-change threshold that was chosen to
identify affected genes. For this manuscript, we chose
a 3 fold-change threshold as our criteria to identify
cryopreservation-affected genes of interest. This ap-
proach applied criteria of higher stringency for
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identifying significantly altered genes while not con-
sidering gene changes that may be associated with
possible background or noise in the systems, and thus
that may not be as important. In addition, our pre-
liminary results (data not shown) indicate that cultur-
ing stored and thawed cryopreserved PBMCs at 37 °C
and 5 % CO2 for 24 h modulates thousands of genes
but only returns approximately 50 % of storage-
modulated genes to baselines levels [35]. This obser-
vation will be the focus of future research and
publications.
There was a total of 1,367 affected genes that showed
a >3 fold-change. The affected genes demonstrated in-
creased or decreased expression and therefore were seg-
regated into 2 clusters, e.g., cluster 1 and cluster 2,
respectively. Sixty-six of these genes were shared among
two or more major stress-related cellular pathways
(stress responses, immune activation and cell death). We
also performed real-time RT-PCR and confirmed the
involvement in these pathways by interrogating 13
genes that may be involved in at least one of these
pathways. Of interest is that there were no genes identi-
fied whose transcripts were increased or decreased by
>3 fold when the Stored −150 °C PBMCs were com-
pared to the Stored −150 °C + Cycled PBMCs, which
underwent cycling between −150 °C and −80 °C. We
chose that temperature range because of how rapidly
samples that were stored at −150 °C can warm above
the GTTW. Our previous work showed that it takes
only 4 min for this to occur when samples are being re-
trieved from a LN2 vapor phase freezer [34]. Recently,
Warhurst et al. also showed that samples removed from
a LN2 freezer crossed the GTTW within 3 min, which
depended on the amount of thermal mass provided by by-
stander vials that surrounded the thermocouple that was
used to measure the temperature. Furthermore, returning
samples back into the LN2 vapor freezer took upto several
minutes to 3 h in order for the vial to return to its original
pre-retrieval storage temperature [36]. As a result, it is
critical to better understand what the minimum amount
of time needed to cause a change in gene expression in
cryopreserved PBMCs is, and does the amount of
time need to be an aggregate of multiple smaller time
intervals or does it require a single but longer time
exposure, as we are suggesting.
In this study, by using microarray analysis we have
begun to examine on a molecular level the possible dif-
ferences between freshly isolated total PBMCs as com-
pared to cryopreserved frozen/thawed total PBMCs. Our
data clearly shows there are differences that resulted
when PBMCs were subjected to the stress of cryopreser-
vation. Even though, we did not evaluate specific sub-
populations of PBMCs, i.e., T cells, B cells, NK cells and
monocytes, we cannot dismiss that some of our results
may be more aligned with a specific cell phenotype. The
focus of this study was to first evaluate total/unfractio-
nated PBMCs, since this is a very common laboratory
biospecimen type used when evaluating an immune re-
sponse. However, future investigations need to explore
the potential contribution of the various mononuclear
cell subtypes.
In addition, apoptosis and necrosis is well documented
to occur during cryopreservation [25–28]. Our micro-
array data identified their involvement in one of the
major stress pathways and our AnnV/7AAD data indi-
cated a decrease in viability that occurred after the
PBMCs were thawed. However, our real-time RT-PCR
data indicates that apoptosis and necrosis cannot ac-
count for all of our gene expression results. As the real-
time RT-PCR data has shown there are gene responses
(IFI16, OAS2 and TNFSF10) that were decreased but
others that were increased (FOSL2, GADD45B, IFI16,
IFNG, MAP3KB and TNF) as a result of cryopreserva-
tion. Furthermore, there were other genes whose gene
expression was enhanced nearly 100-fold (IL1B and
DUSP6) and 2 interferon signature genes that were not
affected (MX1 and MX2). Taken together, the change in
gene expression of some but not all genes may be dir-
ectly regulated by cell viability. Further analysis is
needed to define the mechanism of regulation of those
other activated genes involved during the thawing
process.
Interestingly, it has been shown that double-stranded
breaks (DSB) in DNA can occur in cryopreserved cells
with the subsequent induction of DNA repair mecha-
nisms [37]. H2AXγ detection is a highly sensitive meas-
ure of DSB formation and this type of genotoxicity is
particularly destructive. Phosphorylated H2AXγ forma-
tion can occur as a result of cryopreservation and sub-
optimal storage conditions [37]. Elucidating the degree,
types of DNA lesions and extent of DNA repair in
PBMC consequent to cryopreservation and storage con-
ditions and length of time in storage are areas of current
study in our lab. We have observed double strand DNA
breaks as evidenced by positive gH2AX ser139 detec-
tion as soon as 30 days post cryopreservation in
suboptimally-stored (−80 °C) samples (data not shown).
The induction of H2AXγ in PBMC as a result of
cryopreservation and storage is important because it
supports the idea that DNA damage is potentially
linked to the readily observable increase of apoptosis/
necrosis following the thawing of cryopreserved
PBMC. This provides an opportunity to interrogate spe-
cific molecular-based defensive DNA damage responses.
Determinations of DNA damage and DNA damage
responses is rapidly expanding in research related to
disease states [38–40] and in the investigation of the
specific mechanisms of action of ionizing radiation,
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viral infections, and chemotherapeutic drugs [41–45]
but is currently less understood in cryobiology. There
is also an ever-increasing understanding of the mech-
anisms by which endogenous DNA damage signals
can activate innate immune responses, especially ef-
fects mediated by increased expression of interferons
[46–51]. It has been reported that cryopreserved, as
well as irradiated PBMC secrete Type II Interferon
(γIFN) [52]. This supports a role for the increase of
γIFN expression and in γIFN stimulated gene expres-
sion seen in our study. There is considerable cross
talk between type I and type II interferon (γIFN), and
many IFSG are also TNFα inducible [53]; there was a
strong induction of both in our cryopreserved PBMC
samples.
Cell fate relies partially on DNA integrity and cells
have evolved the ability to detect genotoxic stress, in
order to either induce repair mechanisms or initiate
apoptosis to avoid passing on genetic mutations or de-
veloping into cancerous cells [44]. Recently, it has been
found that PBMC from healthy primates, including
humans, can respond to DNA metabolic stress with
broad up regulation of multiple Toll-Like Receptor
(TLR) genes [50]. As shown in Fig. 5 below, signaling via
TLRs upon recognition of pathogen-associated molecular
patterns, so called PAMPs, induces γIFN and TNFα and
associated cytokines, promoting increased anti-microbial
activities as a part of an activated inflammatory response
[54]. DNA, whether viral DNA or endogenous damaged
DNA, is immunostimulatory. Thus a similarly conserved
immune surveillance system includes the evocation of
inflammatory and cell defense responses following the
detection of cellular damage associated molecular pat-
terns, known as Damage-Associated Molecular Patterns
(DAMPs) [49, 50].
Transcript levels of genes in fresh PBMC samples that
are correlated with cell viability following cryopreserva-
tion may provide insight to pre-storage variables. These
correlations may reflect sample cryopreservation quality,
such as donor immune state, sample handling and sam-
ple processing, and therefore be used as biomarkers of
quality. Use of such biomarkers could provide for rapid
testing of various handling and processing variables
without having to wait long periods of time while sam-
ples go through months of storage.
In particular, interferon stimulatory gene (IFSG)
levels, i.e., OAS2, in fresh PBMC samples compared to
cryopreserved and stored PBMC appeared to predict
cryopreservation quality in our study, as these were in
good agreement with cell viability. Potential biomarkers
in fresh PBMC samples that are predictive of cryo-
preservation quality were identified by selecting genes
from fresh samples that significantly correlated with cell
viability levels of cells stored ≤ −150 °C, ≤ − 150 °C + cy-
cled and stored −80 °C. While a number of potential
biomarker genes were identified (Additional file 2), a
group of interferon stimulated genes were consistently
expressed at higher levels in PBMC samples likely to
Fig. 5 Effects of cryopreservation: An overview
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demonstrate poor cell viability in all three storage
conditions.
The increased expression of the OAS2 gene appears to
be an especially interesting result. This gene product is
present in the cytoplasm of cells and promotes foreign
nucleic acid degradation, specifically via activation of
RNase L and STING (stimulator of interferon genes)
[55–57]. OAS2 is also known to be involved in DNA
damage/apoptotic responses during sterile inflammation
as well [57]. Recently the expression of this gene has
been evaluated in several clinical research PBMC bio-
marker studies. Expression of OAS2 in a triad panel with
two other immune response genes was found to be diag-
nostic of systemic lupus erythematosus (SLE), discrimin-
ating between SLE positive subjects and normal controls
with 94 % sensitivity [58]. In addition to anti-nuclear
antibodies (which can cause DNA damage), and nucleo-
somes detected in blood, DNA damage in PBMCs has
also been reported in SLE patients [40, 59]. Expression
of several TLRs and OAS2 in PBMCs was also suggested
to play a role in advanced prostate cancer via mecha-
nisms of inflammation and innate immunity [60]. While
much more work needs to be done with larger numbers
of samples and experimental conditions, OAS2 expression
in combination with a select subset of other IFSG in com-
bination with accurate viability measurements, may yield
a specific and sensitive quality signature for assessing
PBMC samples. IFN-inducible genes, including OAS2 ex-
pression, are increased in HIV infected individuals taking
antiretroviral treatment and also in elite controllers, con-
sistent with sustained immune system activation despite
suppressed plasma viremia [61].
Future work will need to determine if the IFSG bio-
markers in fresh PBMCs is a marker of sample handling
and processing, or related to the immune state of a
donor, although this seems unlikely since the signature
associate with OAS2 and expression of other inflamma-
tory mediators in PBMC seems indicative of severe dis-
ease, and not healthy donors, as were used in our study.
Likewise, careful evaluation of the contribution of the
vacutainer type and its anti-coagulant including cell
preparation tubes (CPT), wash solutions, cryococktail
formulations, method of cryopreservation, e.g., rate-
controlled freezer, Mr. Frostie, or CoolCell, and thawing
protocol used are all currently being evaluated in the
laboratory.
Taken together these data provide promising observa-
tions relevant to the continuing development and refine-
ment of a sensitive expression signature in PBMC for
assessing cellular damage as a result of cryopreservation.
Importantly, these observations reinforce biomarker dis-
covery for PBMC quality at the interface between
inflammatory processes, innate immunity and DNA
damage cell defense.
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